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CHAPTER I
INTRODUCTION
Worldwide, 70-90% of the population use alternative medicine for pain
relief. 1 There are many forms of alternative medicines that are becoming popular
with people experiencing pain. Most alternative therapies do not require invasive
surgeries or use of medications. One form of alternative medicine that people use is
magnetic therapy. Americans spend more than $500 million annually on magnets to
treat pain. 2 The estimated amount spent on magnetic therapy worldwide is $5 billion?
Many people purchase magnets in stores or over the internet to use on their own
without consulting a health care provider. 3 However, many of the forms of
alternative medicines, including magnets, do not have significant evidence to prove
that they do indeed work.
For hundreds of years, magnets have been used to alleviate pain. Magnets are
said to improve fibromalgia,4 fracture healing,S carpal tunnel syndrome,6 pelvis pain,?
diabetic foot pain,8,9 multiple sclerosis,1O osteoarthritis eOA),11 chronic low back
pain, 12 rheumatoid arthritis pain,13 and tinnitus. 14 Magnets have even been
acknowledged to help physical performance lS and increase range of motion. 16
Philpott & Taplinl? showed that magnetic therapy can improve mood. Magnets are
used in shoe insoles, heel inserts, mattress pads, bandages, belts, pillows/cushions,
bracelets, and other jewelry.2 There has been some published research on the effects
1

of magnetic therapy but more is needed for the safety of the consumers. The medical
community would benefit from more research on magnetic therapy in order to prove
and standardize the treatment options.
Purpose
The purpose of this study was to evaluate the short-term effects of magnetic
insoles on lower extremity (LE) OA pain and function.
Research Questions
1. Is there a significant difference in pain when an individual uses magnetic
insoles?
2. Is there a significant difference in function as self reported on the Short
Form-36v2 (SF36) when an individual uses magnetic insoles?
Significance
The significance of this study was to assess if magnetic insoles decrease pain
and increase functional abilities in people with OA of the LE.
Null Hypotheses
1. There is no significant difference in perceived level of pain with
use of a magnetic insole, a nonmagnetic insole, and no insole.
2. There is no significant difference in perceived level of function
under the conditions of wearing a magnetic insole, a nonmagnetic
insole, or no insole, as self-reported in the SF-36v2 in the physical
and mental aggregate scores.
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Alternate Hypotheses
1.

There is a significant difference in perceived level of pain with
using a magnetic insole, a nonmagnetic insole, and no insole.

2.

There is a significant difference in perceived level of function
under the conditions of wearing a magnetic insole, a
nonmagnetic insole, or no insole, as self-reported in the SF36v2 under the physical and mental aggregates.

3

CHAPTER II
REVIEW OF LITERATURE
Osteoarthritis
Osteoarthritis is defined as "a chronic joint disorder characterized by
degeneration of joint cartilage and adjacent joints that can cause joint pain and
stiffness.,,18 Osteoarthritis is also described by Goodman, Boissonnault, and Fuller 19
as a slow, progressive degeneration of joint structures including articular cartilage and
bone, with joint space narrowing. 19 Two out of 3 people in the United States over the
age of 35 have signs and symptoms of OA. Due to the profound effects on the joints,
many people with pain associated with OA seek medical and non-traditional
approaches to pain management and improvement of function, including the use of
magnetic therapy.
The primary cause of OA has been found to be a defect in the articular
cartilage which leads to degenerative changes in the articular surfaces of the weight
bearing joints such as the hips and knees. Secondary causes of OA include trauma,
infection, hemarthrosis, osteonecrosis, or other pathological conditions. 19 Described
by Goodman, Boissonnault, and Fuller 19 as being driven by mechanical forces but
mediated by biomechanical processes, OA is an active disease process and generally
not the result of general "wear and tear" on a joint. The disease process begins with
the loss of cartilage which leads to joint inflammation and bony overgrowth with
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osteophyte development. As there is no cure for OA, joint changes then lead to
muscle weakness and atrophy, ligamentous laxity, and joint pain. Signs and
symptoms of this disease process include: pain, deep ache, stiffness, crepitus,
swelling, and decreased flexibility of the joint. 19 Although often relieved by rest,
these symptoms can greatly impact a person's life and lead to the necessity for
medical treatment.
The most prevalent risk factors of OA are age,20 poor weight control,19 muscle
weakness ,20 joint laxity,20 decreased bone density,19 genetics,19,20 local biomechanical
factors,19 and a life of inadequate diet and lack of exercise. 18,21 In many cases, serious
injury of a joint, especially the hip, has been found to lead to OA of the joint. 19 Sport
activities can lead to degenerative changes of OA if they are high intensity, high
impact, repetitive, and include twisting of the lower extremities. 19
Factors placing individuals diagnosed with OA at high risk for decreasing
function include proprioceptive inaccQracy, knee pain intensity, and a high Body
Mass Index (BMI),zo Factors which increase a person's functional ability with OA
include strength, mental health, high self-efficacy, increased social support, and a
greater amount of aerobic exercise per week. 2o Many of the people diagnosed with
OA experience the need to reduce the amount of exercise and weight bearing
activities in their lives due to pain in their joints. This sedentary lifestyle leads to
increased weight and/or obesity, which puts more stress on the joints and begins a
continuous destructive cycle. Combined with decreased lower extremity function,
this cycle has been shown to increase the chances of osteophyte development in a 5
year study,z2
5

Reducing the effects and progression of OA is a primary goal of treatment.
Adequate amounts of Vitamin D and Vitamin C in the diet as well as early diagnosis
and intervention has been found to slow the disease process. 19 Traditionally
prescribed medications to decrease pain and degenerative changes associated with
OA include COX-2 inhibitors, nitric oxide synthesis inhibitors, antioxidants, bone
growth promoters, metalloproteinase and cytokine inhibitors, and gene therapy.19
Additional medications can include aspirin, corticosteroids, intramuscular and intra. I ar
artlCU
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ability include weight control and exercise combined with strength training. 19 Self
management techniques that are increasing in popularity include TENS, acupuncture,
hot and cold packs, pacing of activities, relaxation techniques, yoga, Tai Chi, goal
setting, food supplementation such as glucosamine, and the use of walking aids or
insoles. 19,23 Another therapy becoming popular for patients with painful OA is
aquatic exercise which has been proven to reduce pain in weight-bearingjoints. 25
With the expanding popularity of these pain-reducing therapies, people are also trying
other alternative therapies such as magnetic energy for pain reduction and improved
function.
Magnets
Humans have been utilizing the power of magnetism for thousands of years.
A lodestone (magnetite) mine dating back 100,000 years was located in Africa where
magnetite was used in foods, potions, and creams to alleviate many dIfferent
conditions.z6 It is thought that many civilizations, including the Chinese, Egyptians,
Hebrews, Indians, and Greeks used magnets to cure illnesses, heal various conditions,
6

and relieve pain. 26 In 1000 A.D., a Persian physician documented the use of magnets
to relieve gout, muscle spasms, and other disorders. 14 Although the shape and size of
magnets have changed, the basic principal in a magnetic therapy has remained the
same. Natural (permanent) magnets are composed of a north pole, which has a
negative charge, and a south pole which has a positive charge. Opposite poles attract
each other and like poles repel. Magnets are able to produce their magnetic fields
without an electrical current being present. Today, over 100 million people
worldwide use magnetic therapy to counter the effects of pain, stress, and various
conditions on the body.14 In Japan, magnetic therapy is popular due to research
findings that show magnets to be effective for the treatment of pain.27 A natural
magnetism exists in objects such as the loadstones used in Africa, the human body,
and the sun. Dr. Kyoichi Nakagawa, director of Tokyo's Isuzu Hospital, believes that
the proven decreasing magnetism of the sun causes a magnetic deficiency syndrome
in the body which increases the population's need for additional magnetism in their
lives. 14,27 Symptoms he has associated with this syndrome include migraines, lack of
energy, insomnia, general stuffiness, aches, pains, lower back problems, memory
loss, and changes in heartbeat and blood chemistry.14,27 It is these factors that
Nakagawa believes are the fundamentals behind the disease processes tod ay l4,27 and
leads to the need for the application of magnetic therapy on the human body.
Factors that can influence the effects of a magnetic field on the body include
the duration of time the magnetic device is in contact with the body, strength and
polarity of the magnet, geometric configuration, depth of penetration, and anatomical
placement. 27 The recommended duration of magnetic therapy use for the therapeutic
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effect of magnetism to occur varies by study. However, most studies agree that there
is an immediate effect on the body when magnets are applied to it. 6, 10, II , 12, 13, 14, 28
When assessing length of time for effects to occur, it is important to consider the
strength and polarity of the magnet because these factors can alter the affects on the
individual. It is also important to consider factors such as age, the length and
condition of the disorder, climate, and response of the body because these factors can
affect the participants' response to magnetic treatment. Depending on these factors,
treatment times can vary from seconds to months. Several studies report bodily
changes due to magnetic therapy to be present after two weeks of utilizing the
therapy.7, 11,29
Polarity of a magnet refers to the direction of the magnetic force. 3o It has been
shown that the negative polarity is safe for treatment of most disorders, especially
when using high strength magnetic fields for a long exposure. 3,30 Negative magnetic
energy is used to normalize human cellular metabolic function , heal tissues, and calm
the human body.3o When positive magnetic energy is used incorrectly, or overused, it
can cause adverse effects on the tissues, or cause traumatic side effects such as
altering nerve conduction or blood flOW. 14
Magnetic fields pass freely through the body; the penetration of a magnetic
field is directly related to the mass and the strength of the magnet. 14, 17 The strength of
a magnet depends on the material used, shape, weight, size, and polarity. A gauss
meter measures the strength of the magnet by the amount of iron-weight it can lift. A
gauss unit (G) is the force of attraction that is measured at the surface of a magnet. 14

In order for magnetic therapy to be effective, research shows that the strength should
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be at least 500 G. 3,27 An example of an insole, sold by American Magnet, has 15
alternating vertical bands of lOOG each in the positive and negative fields. This
alternating polarity produces a magnet with a weak strength of lOOG over all.
Geometric configuration patterns of magnetic fields within a magnetic therapy
device can include parallel lines, circles, triangular-board, or checkerboard patterns.!6
The arrangement of the magnets used in products influences the strength of the
magnets overall. The strongest pattern proven effective for a magnetic insole is a
triangular-based grid. 3 The magnetic insoles produced by American Magnet utilize a
parallel line configuration. A study aimed to test the effectiveness of arrangements of
static magnetic fields found that a whole-body, negative-field sleep pad reduced pain
to a greater extent than a sham mat containing magnates of varying polarity.
However, participants using either of the magnetic pads experienced improvements in
functional status, pain intensity, and tender points.
The effects of magnets on the human body are not proven in every case;
however, many effects are theorized to occur in individuals treated with magnetic
therapy. These effects include balancing the equilibrium between cell death and
growth,24 increasing blood flow while increasing the delivery of oxygen and nutrients
to the tissues,3! dilation of blood vessels,3! increase the production of white blood
cells,2o reducing fluid retention and inflammation,24 and increasing connective tissue
relaxation. 32 It is also important to take into account the possibility of these effects
causing unforeseen complications with pre-existing conditions. Magnetic therapy is
not recommended for everyone. Contraindications include women who are pregnant
as there is unknown effects on the fetus, consumers with an implanted device such as
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an insulin pump, pacemaker, defibrillator, TENS unit, or cochlear implants should not
use magnets due to the possibility of disruption of the magnetically controlled
features of the devices, people who use a medication patch which magnetism may
effect the delivery of the medication. Those persons taking anticoagulants or have a
platelet disorder, Myasthenia Gravis, or hyperthyroidism should not use magnetic
therapy due to the increased bleeding that can occur with application of magnetic
fields. This caution also applies to persons with infections or wounds which may be
adversely affected by the magnetic field. Magnetic therapy is also not recommended
for those persons with cancer due to the increased circulation and possible spread or
metastasis within the body. There are some potential side effects that have been
reported from improper use of magnets, such as headaches, pain, insomnia, seizures,
digestive problems, toxin release, tumor growth, dizziness, hyperactivity, and
medication interactions. 32
Magnetic Therapy and OA
Research shows conflicting results in the effectiveness of magnetic therapy for
relief of pain from OA. One study reviewed 3 randomized control trials of pulsed
electromagnets used on patients with OA of the knee and of the neck which
demonstrated that magnets had a small to moderate effect on knee pain and a much
smaller effect on neck pain. 28 The researchers concluded that the current limited
evidence does not show a clinically important benefit of pulsed electromagnets for
treating OA of the knee or neck and that there is a need for larger trials to prove
whether significant benefits do exist. 28
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Another trial utilizing pulsed electromagnet therapy with OA had participants
use a placebo device or a Pulsed Electro Therapy (ET) device placed on or between
the knees for 10 minutes 3 times per day?3 Pulsed ET significantly reduced pain, over
a 6 week period in the treatment group, and did not produce any adverse effects. No
improvements were noted with the placebo-treated group. The authors suggested
further studies are needed to assess Pulsed ET for OA and other conditions. 33
A third method of using pulsed electromagnetic therapy had participants with
OA of the knee lay on a pulsed electromagnetic mat or a sham mat for 30 minutes
twice a day for 6 weeks. At the end of the 6 week trial, physical function scores were
significantly improved for the treatment group compared with the sham group while
pain and stiffness decreased for both groupS.34 Therefore, no significant difference in
pain and stiffness was found between the groupS.34

In a study utilizing static magnetic fields for treatment of pain associated with
OA of the knee gave subjects a knee sleeve which either contained magnets, or was a
placebo sleeve without magnets. Knee pain was measured at 4 hours, 1 week, and 6
weeks. There was a statistically significant improvement in pain in the treatment
group at 4 hours, but no significant difference was found at 1 week or 6 weeks. 33 This
study indicates that a 1 week or 6 week wearing period had no effect on knee pain
compared to a 4 hour assessment.
Marketing campaigns for magnetic insoles target individuals with diagnoses
of OA of the foot, knee, and hip although limited research is available to determine
the validity of the claims. Research concerning heel pain, however, has demonstrated
results of decreased pain and increased function. 35 One study that assessed the effects
11

of magnetic insoles on plantar heel pain found no significant differences in pain
outcomes between participants who received either shoe insoles containing a magnet
or insoles that were identical except for having no magnet. Participants wore the
insoles at least 16 hours per week for 2 months and kept a daily pain diary to measure
outcomes. Both groups experienced significant improvement in morning foot pain
and in enjoyment of their jobs although no significant differences were found
between treatment groupS.35
Various magnetic therapy devices have been researched to analyze their effect
on pain and function in people with OA. It is do to the limited research available
concerning static magnetic fields for the improvement of pain arid/or function in
persons with OA that further research is needed to evaluate magnetic therapy use in
this population. Assessments used for the evaluation of pain and function in persons
with OA are also key to the research of magnetic therapy's effects on a person and
vary widely in their use in clinical settings.
Evaluation Measures for Pain
Several effective pain measures have been identified for various populations
including the verbal, numerical, or line graph Visual Analog Scale (VAS),36 verbal or
written reports,3? the McGill Pain Questionnaire,3? the modified pain chart,3? and
pain diaries. 3? The VAS (Appendix A) has been proven valid and reliable with many
populations of people in pain 38 and those with chronic pain 36 such as the pain caused
by changes associated with OA. Two versions of the VAS include the absolute and
comparative scales. 36 The absolute scale represents a person's pain at that moment in
time while the comparative scale allows comparisons to previous scores to show
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changes in pain over time. 36 The absolute scale has demonstrated greater reliability in
clinical testing than the comparative scale. 36 Barker, Lamb, Toye, Jackson, and
Barrington 39 used the VAS pain rating scale to compare pain felt by people with OA
and the radiographic findings indicating the disease progression. The researchers
found that pain scores had greater clinical correlations with physical functioning than
radiographic scoring. 39 A study evaluating the effects of an aquatic exercise program
on participants OA pain used the VAS to evaluate changes in pain over the course of
the study.24 The VAS is widely used in OA literature to assess the pain felt by people
with OA and the changes experienced through treatment. 24,35,39
Evaluation Measures for Function
Radiographic scoring or grading of OA of the lower extremities is often done
prior to joint replacement surgeries to assess the degree of OA involvement in the
joint but may not be the optimal choice for analyzing changes in function of the
persons with OA. 22,39 The Kellgren and Lawrence scale of radiographic grades
indicates the level of pathology from 0 to 4 with zero being no osteoarthritis
development and 4 being severe involvement. 39 Although these techniques are
commonly used by surgeons, Barker, Lamb, Toye, Jackson, and Barrington,39 studied
patients prior to joint arthroplasty and discovered that there were considerable
variations in function, pain and power among participants with the same radiographic
score. Two studies have found that pathological level of involvement or radiographic
findings are not predictive of patient pain or function with OA leading to the
necessity of the development of other testing procedures. 39,40
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Reproducible physical function tests which diagnose and track the effects of
OA on the body include on-the-spot marching,41 walking up and down stairs,41
completing a maximum number of strait leg raises,22 and a repeated chair stand
exercise?O These examinations have been designed to assess the functional impact of
OA on the person as a whole. They have also been proven to be effective in
evaluating changes in patient's function through the course of treatment or disease
progression. 20 ,22,41
Also effective for tracking changes in function and health are self-report,
health related quality of life (HRQOL) questionnaires such as the Short Form-36 (SF36) (Appendix B), which make it easy for a patient and therapist team to assess a
patient's progress in treatment. The SF-36 is a self reporting questionnaire covering a
person's functional abilities and perceived quality of life. The second version of the
Short Form-36, the SF-36v.2, was developed to be a more "international version" of
the first edition and contains improved instructions and item wording, improved
layout, increased comparability for cultural and translational adaptations, and an
adapted 5-point scale as opposed to the original 7-point scale. 42 The SF-36v.2 is
recommended for population surveys, outcome research studies, controlled clinical
trials, and clinical practice with individual patients. Questions on the SF-36v.2 are
rated to indicate the level at which the participants health has effected different
aspects of their life over the past week. For example, Question 1 asks "In general,
would you say your health today is:" with response options: "1. Excellent, 2. Very
Good, 3. Good, 4. Fair, or 5. POOr.,,42 Norm-based scoring algorithms have been
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developed and researched to maximize reliability and validity of the SF-36v.2 making
it a standardized test which is accepted in many fields. 42
Salaffi, Carotti, and Grassi 43 conducted a study which compared the Western
Ontario and McMaster University (WOMAC) OA-specific questionnaire with the
more broad SF-36. Their findings indicate that the WOMAC may be the instrument
of choice when assessing only the consequences of knee and hip OA in elderly
patients. 43 The SF-36 was found to be better at assessing general function, nonmuscular co-morbidities and physical limitations in this population. 43 Both the
WOMAC and the SF-36 are self-reporting questionnaires with the WOMAC covering
only the participants' perception on their pain, stiffness, and physical functional
disabilities. 43 Due to the multiple effects that magnets have on the body and the
likelihood of co-morbidities, it is important that assessments of many factors are
included in this study, leading to the utilization of the SF-36 as the functional
assessment measure. Davey, Edwards, and Cochrane44 proved the SF-36 to have testretest reliability in participants with lower extremity OA. The mental health and rolefunctioning areas of the SF-36 have been proven to accurately predict physical
function outcomes in participants with OA in a 3 year study?O
The SF-36v.2 assesses general health and quality of life including all parts of
the body including the feet. Foot pathologies range from infections and ulcers, to
deformities and cancers, making it important that feet are assessed whenever
something new is added to the shoe. 45 Also, co-morbidities such as diabetes are
common in people with OA and it is highly recommended that foot health be assessed
regularly to prevent skin breakdown and monitor sensory changes.
15

Foot Screenings
Routine foot screenings are important for the vast majority of the older
population due to the rising number of people with diabetes and the fact that there is
no treatment available for peripheral neuropathy caused by diabetes.46 It is estimated
that 15% of all hospital admissions for diabetic patients are related to peripheral
infections. 45 By identifying those at risk for ulceration, preventative measures can be
taken to avoid any changes in peoples' feet prior to complications or diabetic
diagnosis. To identify those at high risk of ulceration, it is imperative that an
effective screening tool is designed for screening purposes. 46 A common device used
to assess lack of protective sensation in many populations is the Semmes-Weistein
monofilaments. This set of 20 nylon filaments with standardized lengths and
diameters, which buckle at a designated, reproducible force. 46 Authorities recommend
that 10 sites are tested on each foot with 9 sites on the plantar surface and 1 site
between the first and second toes to assess all dermatomes on the foot. 47 Singh et al 47
found that only 4 testing sites are needed to adequately assess sensation changes and
has proven reliable in detecting changes in 90% of the population.
In addition to sensation testing, assessments for foot pathologies including
ulcerations, pedal pulses, and deformities are needed for people with OA of the LE.
Ulcers of the feet occur when continuous trauma is applied to a specific area leading
to a loss of protective adipose tissue. 48 Nutritional supply to the area is then
diminished in people with vascular disorders or may occur through neuropathy.48
Infections may cause few if any symptoms leading to delay of treatment and
increasing involvement of surrounding tissues. 45 The warm, moist environment
16

experienced by feet when confined in shoes for several hours each day increases the
likelihood for infections. 48 It is also important that pedal pulses be assessed due to the
prevalence of Peripheral Artery Disease in the aging population and the effects of this
disease on a person's feet. Although truly absent pedal pulses can only be assessed
using Doppler technology, notations of diminished or absent pulses with palpation
should be referred to a physician for further assessment. 45 Absent, diminished, and
normal pulses identified with palpation is a standardized and reproducible physical
assessment. 45 Although unlikely in smaller vessels, bruits in the artery should also be
recorded if present. 45 Common foot deformities include hallux valgus, claw toes, and
nail pathologies which may become worse with the addition of something in the
shoe48 such as an insole.
Magnetic insoles are believed to benefit people with foot, knee, hip, and low
back pain through the magnetic properties described previously. Because it is
common for OA to affect these joints of the LE, magnetic therapy may be a modality
to assess when analyzing various treatment options for people diagnosed with OA.
Therefore, it is the focus of this study to evaluate the short-term effects of magnetic
insoles on pain and function in people with OA of the LE.
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CHAPTER III
METHODS
Subjects
Subjects were recruited by advertisement (Appendix C), word of mouth, and
personal acquaintances of researchers. During the initial phone conversation with
potential subjects, general qualification questions were asked and size of shoe was
obtained from the participants. Insoles were purchased prior to each participant's
first meeting based on the size each had reported during the initial conversation.
Potential subjects were informed of details of the study and given the opportunity to
ask questions and discuss concerns prior to deciding to participate in the study.
Approval for the use of human subjects for this study was obtained from the
University of North Dakota Institutional Review Board. (Appendix D)
Ten people volunteered to participate in the study, 2 were excluded due to
time conflicts and not meeting inclusion criteria. Eight subjects (3 males, 5 females;
mean age of 55.85 years) met the necessary criteria to be included in this study:
1. Previously diagnosed with OA in one or more joints in their LE
2. Age 18 years or older
3. Physical pain in the lower extremity
4. No implanted metal device in the foot or ankle
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5. No pacemaker, cochlear implant, or other implanted device which have
possible adverse affects from external magnetic field
6. No known myasthenia gravis, hyperthyroidism, platelet disorder, spinal
neoplasm, cancer, or pregnancy at the time of the study
7. Not on anticoagulant medications
8. No evidence of adverse findings in the foot examinations and not currently
using foot orthotics
9. Participants must also be able to rate their pain on the Visual Analog Scale
(Appendix A) and complete the SF-36v2 Functional Assessment
Questionnaire (Appendix B).
Subjects were not excluded from this study due to prior joint arthroplasty of the knee
or hip or current use of over-the-counter or prescription medications.
Instrumentation
At the beginning and end of each 2 week insole-wearing period, participants
completed the VAS, SF-36v.2, and had their feet assessed by the investigators. Pain
was assessed using the 0-10 V AS with 0 signifying no pain and 10 equaling the most
extreme pain they can imagine experiencing at that time. The V AS has been
established as valid and reliable. 38
The SF-36v.2 is a self-report questionnaire used in assessment of perceived
physical and mental functioning prior to and during the wearing periods. The SF36v.2 contains 36 questions with 1-3 and 1-5 ratings for functional abilities.
Research has demonstrated that the SF-36v.2 is useful in assessing functional changes
over time in people diagnosed with OA. 42 ,43,44
19

Participants' foot health data was collected using a foot assessment (Appendix
E) devised by the investigators to assess skin and nail integrity, sensation, and
circulation. Adverse reactions of the feet in these areas would have been identified
by this assessment.
Procedure
Potential participants completed a Participant Survey (Appendix F) which was
used in assessment of inclusion criteria and resultant demographical analysis. Once
potential subjects were screened for the inclusion criteria and agreed to participate in
the study, each participant signed the Consent Form (Appendix G) and were given a
copy for their records. The individuals recruited for participation in this study were
informed that their participation was voluntary and that they could withdraw at any
point during the study without consequences. Subjects then completed the pain
assessment on the VAS, the SF-36v2, and received the initial foot assessment.
Eligible participants were randomly assigned to 1 of 2 groups depending upon which
insoles they were to wear first, magnetic or non-magnetic.
The magnetic insoles were those produced by American Magnet and had a
cumulative strength of 100G. The insoles were made up of 15 bands of alternating
polarity running the length of the insoles. Five participants wore these insoles during
the first wearing period. The non-magnetic insoles were Dr. Scholls Cushion
Insoles. Three participants wore the non-magnetic insoles during the first wearing
period.
For the initial meeting, participants were asked to wear the shoes in which
they would wear the insoles at least 8 hours each day during the study. The
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investigators then fit participant's shoes with the insoles which each had been
randomly assigned to wear. If needed, the insoles were cut to fit the size of the shoes.
Once fit of the insoles had been established, each participant was given a Wearing
and Activity Log (Appendix H) on which they were asked to record the hours they
wore their shoes with the insoles each day and general activities performed while
wearing the shoes with insoles.
After 1 week, each participant was called by an investigator and was asked to
rate their pain on the VAS. Participants were questioned about the fit of the insoles
to identify possible adverse affects which may have been caused by the insoles. The
participants were given the opportunity to ask any questions that had come up over
the past week.
At the end of 2 weeks, participants met with a researcher, reported their pain
on the VAS, and completed the SF-36v2. Participants' feet were assessed at this time
to identify any adverse affects that may have occurred during the insole wear.
Participants also turned in their completed Wearing and Activity Log to the
researcher.
For a period of at least 1 week following the first trial, no insoles were worn
by the participants. At the end of this time period, each participant returned to be refit
with the opposite type of insoles from the type worn during the first 2 weeks of the
study. Each subject gave a pain rating on the VAS, filled out the SF-36v2, and
received a new Wearing and Activity Log. The foot assessment was completed by
the investigators at that time to assess any changes that may have occurred during the
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previous time frame and to identify any reason for the participant to be discontinued
from the study.
Following a week of wearing the second pair of insoles, each participant was
again called by an investigator. Participants were given the opportunity to express
any concerns and were asked for a pain rating on the VAS. Participants were
questioned about the fit of the insoles to identify any possible adverse affects caused
by the insole wear.
At the end of the second 2 weeks, each participant was assessed by an
investigator for a final time. Pain was reassessed with the VAS, and overall function
was reassessed with the SF-36v2. Participants also turned in their Wearing and
Activity Logs to the investigators. Participants' feet received the final foot
assessment at that time to ensure they had maintained the health of their feet and had
no adverse affects caused by the insoles. Participants were allowed to keep the
insoles they wore as compensation for completing the study.
Data Analysis
Transformation of data was completed following the standardized procedure
for analyzing the SF-36v.2, and statistical analysis was completed using the Statistical
Package for Social Sciences (SPSS) version 11.5.49 The independent variables
identified for this study were the type of insoles worn by the participants. The
dependant variables were the participants' pain and level of function. Univariate
Analysis of Variance (ANOVA) with a repeated measures design was completed for
pain on the V AS and the 2 factors, physical and mental aggregates, identified through
completion of the SF-36v.2.
22

CHAPTER IV
RESULTS
Subjects
All 8 participants completed the study; demographics are presented in Table 1.
All participants' self-reported wearing times averaged above the recommended 8
hours per day for the total 2 weeks in each wearing condition. No mean difference
(x= 9.62, SD=1.87) was found in the hours participants wore the magnetic or
nonmagnetic insoles. Thus leading to the conclusion that the hours worn did not
effect data analysis and had no alternate effect on the participants' pain or function
data.
Pain
The means and standard deviations for pain scores were not statistically
significant for demonstrating a decrease in participants' pain during the study (Table
2). Pain scores were entered and analyzed using the univariate, repeated measures,
ANOV A. The tests of between-subjects effects of pain revealed no significant

difference between participants who wore magnetic or non-magnetic insoles during
either of the 2 wearing periods [F(5,I9)=1.382, p=.275, power=.38I] (Figure 2). The
insoles the participants wore, magnetic or nonmagnetic, had no effect on participants'
pain level during either of the 2-week wearing periods or during the no-insole
wearing period.
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Table 1: Participant Demographics
Demographic
Male
Female
OA:
Hip and knee pain
Hip, knee, and low back pain
Knee pain only
Joint Arthroplasty:
Unilateral hip arthroplasty
Bilateral hip arthroplasty
Medications used for pain relief:
Tylenol
Ibuprofen
Aleve
Flosomex
None
Previous magnetic insole use
Participant beliefs in magnetic therapy
for pain control:
Believed in magnetic therapy
Did not believe in magnetic therapy
Did not respond
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Number of
Subjects
3
5
8
4
1
3
2
1
1
6

3
1
1
1
2
0

2
2
4

Table 2' Pain Means and Standard Deviation
Mean
Time, Insole
Initial, no insole
3.63
2.33
First wear, non-magnetic insole
First wear, magnetic insole
3.80
2.63
Post break, no insole
Second wear, non-magnetic
3.6
insole
Second wear, magnetic insole
2.00

Standard Deviation
2.26
1.15
1.30
2.13
1.95
1.00
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Figure 1: The 95% confidence intervals of the means
for pain scores reveal no significant statistical change
in that the intervals overlap greatly and represent no
change between the reported pain before or after any
of the insole use.
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Function
There was no significant difference between the physical (Table 3) or
mental (Table 4) aggregate means and standard deviations of the magnetic and
nonmagnetic insole wearings. Tests of between-subjects effects on the
transformed physical aggregate scores revealed no statistically significant
difference in physical scores between wearing times [F(5,19)=.695, p=.634,
power=.199] (Figure 3).

Also, tests of between-subject effects on

transformed mental aggregate scores revealed no statistically significant
changes in mental scores between wearing times [F(5,19)=.338, p=.884,
power=.115] (Figure 4). Therefore, perceived health and role function was
unaffected by the insoles worn by the participants.
Foot Assessments
The Foot Assessments that were completed at the beginning and end
of each insole wearing period showed objective changes with only 1
participant. The monofiliament tests for sensation and the dorsal/pedal pulses
assessment showed no changes with any participant. However, the skin
integrity check showed changes in one participant. One participant developed
blisters on her feet during the first week of the second wearing time, the
magnetic insole period. This participant was not removed from the study
because she chose to continue wearing the insoles and reported her pain was
unaffected by the blisters which were almost healed by the final assessment.
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Table 3: Physical Aggregate Means and Standard Deviations
Time, Insole
Mean
Standard Deviation
Initial, no insole
39.59
7.43
First wear, non-magnetic insole
38.87
6.32
First wear, magnetic insole
41.43
5.80
Post break, non insole
40.79
6.45
Second wear, non-magnetic insole
41.52
7.04
Second wear, magnetic insole
42.92
3.07
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Figure 2: 95% confidence interval of the means of
each test condition regarding physical aggregate scores.
As this visual representation of the data depicts the error
bars overlapping, this demonstrates that the difference
between the means in not statistically significant for the
conditions.
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Table 4: Mental Aggregate Means and Standard Deviations
Mean
Standard Deviation
Time, Insole
Initial, no insole
53.14
7.89
58.16
1.09
First wear, non-magnetic insole
53.09
6.41
First wear, magnetic insole
Post break, no insole
53.97
5.08
Second wear, non-magnetic insole
52.03
5.49
Second wear, magnetic insole
58.84
3.30
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Figure 3: Data demonstrates that with small sample
size and overlapping effort bars, the 95% Confidence
Intervals of the means were not statistically significant
between testing conditions.
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CHAPTER V
DISCUSSION/LIMITATIONS AND CONCLUSION
The use of magnetic and non-magnetic insoles for pain relief and
improvement of function in people with OA pain was not supported by the findings in
this study. Statistical data revealed that there was no significant difference in pain or
function as reported on the VAS and/or SF-36v2 under any of the testing conditions.
Participants experienced no statistically significant changes in pain or function from
initial testing to after wearing magnetic or non-magnetic insoles, and after a no-insole
wearing period. Both mental and physical aggregate scores on the SF-36v2 revealed
no statistical change between conditions. This evidence supports the null hypothesis;
magnetic and non-magnetic insoles had no effect on pain and function in people with
OA in this study.
Participant factors which could have affected the outcome of this study
include: age range of participants and effects of OA on their person, activities
engaged in, beliefs in magnetic therapy, and additional personal choices in regards to
how they wore their insoles. Additional factors that could have influenced results
include: evaluation procedures, small sample size, length of time and time of year that
the insoles were worn, strength of the magnets, and the fact that the study was not
blinded. Individually or in combination, all of these factors had the potential to limit
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the effects of magnetic insoles on the participants' pain and/or function during the
study.
The age of participants in this study was approximately 55 years, and because
. of the small sample size, no statistical data was done to determine age related OA
changes. With OA, the longer the person has pathological changes within the joint,
the more intense the symptoms may become over time. The participants' initial
severity of pain (x: 3.63, SD: 2.26) may have had an effect on the results when
assessing changes of pain and function.
Participants' daily activities were not restricted during the study, only the 8
hours of daily insole wear time was recorded and reported by the participants.
Although participants were asked to fill out logs to assess their average activities,
these activities were not controlled, and many participants were not descriptive of
their activities on the forms. This difference in activities may have made an impact in
their pain and function. Subjects may have been more active these summer months or
had different types of activities in their lives. This activity could have caused
increased or decreased pain and changes in functional abilities. Future studies may
wish to standardize activities or consider a pedometer to track level of activity of the
participants over the course of the study.
This study was not blinded, and the subjects knew which insole they were
wearing during each time period. Preconceptions of alternate therapy could have had
a psychological effect on subjective data. On the initial survey, a question asked if
each believed in magnetic therapy. Four participants chose to leave this question
blank, 2 reported positive feelings towards magnets use for pain relief, and 2
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disagreed with the potential pain relief qualities of magnetic therapy.(Table 1) The
researchers did not attempt to influence participants' beliefs during the initial intake
or during the course of the study.
The participants also provided limitations for this study; they made personal
choices that may have influenced data reporting. For example, one participant chose
to wear her insoles with her sandals. Although recommended to wear shoes, this
participant developed blisters from gluing her insoles to the bed of her sandals to
make them stay put. Another participant, who did not wear orthotics at the start of
the study, chose to insert her insoles over orthotics at some point during the first week
of the magnetic insole wear. This change could have affected the position of the
insole relative to the foot. Specific initial instruction for participants regarding these
unanticipated actions or guidelines for researchers' data inclusion following in these
types of circumstances would benefit future studies on insole use.
Data was reported subjectively by the participant, and there were no objective
recordings done to ascertain diagnosis and progression. Objective data, such as
radiographs 39 ,40 or physical function testing,

20,22,41

may have demonstrated changes

due to the insoles that the participants were unaware of in their subjective reports.
Investigators did not request that participants provide written proof from their
physicians of the diagnosis of OA, and no functional tests were performed to quantify
the extent of OA involvement in the participants' LE. Pain is difficult to measure
since it is subjective and depends on multi-causative factors. 39
The small sample size decreased power in data analysis. A larger sample size
may be warranted to demonstrate the effects on a population with OA. Also, no
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analysis was done on the placebo effect in this study. A blinded study may have
altered participant's self-reported pain and function differences.
The subjects wore the magnetic insoles for 2, 2-week time periods with a
minimum of 1 week break between wearing periods. Although researchers have used
a 2-week time frame and stated that significant differences in subjects symptoms were
found, the results of this study do not support the findings that a 2 week time period is
sufficient for demonstrating changes in pain and/or function. 7, 11,29 Pain and function
scores may have shown greater changes with a longer wearing period. Due to the
subjects wearing the insoles during different times of year, weather may also have
had an effect on symptoms along with the shoes participants chose to wear during this
time period.
Other factors that had the potential to influence results were the magnetic
strength of the insoles, configuration, and polarity. Compared to the recommended
500 G 3,27 strength of magnetic insole, the strength of the American Magnet insoles
were weak, measuring only 100 G. A triangular-based grid configuration3 has also
proven most effective for magnetic therapy treatments. This study used the American
Magnet insoles which were arraigned in a parallel band configuration. Negative
polarity is recommended to increase human cellular metabolic function, heal tissues,
and calm the human body.3o The American Magnet insoles consisted of alternating
bands of positive an negative polarity.
Clinical Implications
Due to the high number of people using magnetic therapy, it is important for
health providers to be educated and aware of the effects of magnetic therapy. Patients
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who may be using alternative therapies, such as the use of magnetic therapy, may not
be aware of possible side effects and contraindications to the therapy they have
chosen to apply to their body. By encouraging patients to report alternative therapy
use to providers, providers can discuss research with their patients on what has been
shown to be effective and minimize potential adverse affects. With many types of
pain relief available, it is important for clinicians to be aware of the available uses and
effects of these therapies.
Conclusion
Under this study's conditions, we found no significant difference in pain with
the use of magnetic insole, nonmagnetic insole, and no insole. We also found no
significant difference in function under the conditions of wearing a magnetic insole,
nonmagnetic insole, or no insole as self-reported on the SF-36v.2 under the physical
and mental aggregate scores. Statistical analysis revealed that no significant
difference was found in mental and physical aggregate scores during any of the
wearing periods. This data gemonstrated that the participants in this study felt no
decreases in pain or increases in functional abilities during this study as reported on
the VAS and SF-36v.2.
As we discovered with this study, manufacturers are marketing products to
groups of people who may not experience any significant change in their pain or
functional abilities due to the product they purchase. Providers may be asked to
educate patients on the potential effects of these therapies so that consumers can
make educated decisions about what they choose to use on their body. As people
today are increasing their use of alternative therapies, including magnetic therapy, it
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is important that more evidence based research is done to determine the possible
effects and benefits of these therapies. Potential areas for further research include:
age of participants, activities participants engage in, length of time the magnets are
worn, strength of the magnets, and a larger sample size. Additional evaluation
procedures to examine the involvement of OA in the participants' LE and functional
testing may also be considered.
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APPENDIX A

Magnetic Insoles
Participant Pain Questionnaire

ID#: - - -

Circle the number that describes your pain today:

o
None

1

2
Some

3

4

5

Moderate

36

6

7

8
A Lot

9

10
Severe

APPENDIXB

Your Health and Well-Being
This survey asks for your views about your health. This information will help
keep track of how you feel and how well you are able to do your usual
activities. Thank you for completing this survey!
For each of the following questions, please mark an !:8J in the one box· that
best describes your answer.

1. In general, would you say your health is:

Excellent

Very good

Good

2. Compared to one year ago,

ho~

Fair

Poor

would you rate your health-in g~neral

~?

SF-36v2™ Health Survey © 1996, 2000 by QualityMetric Incorporated and Medical Outcomes Trust. All Rights Reserved.
SF-36® is a registered trademark of Medical Outcomes Trust
, ... ,... ... ,
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.... '"
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3. The following questions are about activities you might do during a typical
day. Does your health now limit you in these activities? If so, how much?

I

...

Yes,
limited
a lot

Yes,
limited
a little

No, not
limited
at all

• Vigorous activities, such as running, liftIng
heavy objects, participating in strenuous
sports ............ ... ... ........ .... ......... ..... .... ..... ........... ... .01 ................... 02 .................. 03
Moderate activities, such as moving a table,
pushing a vacuum cleaner, bowling, or
playing golf ................................................ .. .... ..... 01 ................... 02 ..................

03

e

Lifting or carrying groceries .................................. 01. .................. 02 ..................

03

d

Climbing several flights of stairs ...... ... .. ................. OI. .................. 02 .........../.. ... 03

e

Climbipg one flight of stairs ..... .............................. 01 ................... 02 ....... ........... 03

f

Bending, kneeling, or stooping ............ ...... ............. OI. .................. 02 .................. 03

g

Walking more than a mile ............................ .......... 01. .................. 02 .. ................ 03

h

Walking severalbundred.yards .............................. 0, ................... 02 .. ................ 03

i

Walking one hundred yards .................................... 01. .................. 02 .................. 03

j

Bathing or dressing yourself.. .................................OI. .................. 02 ..................

b

Sf'~36v2'·M Health Survey © I 'J96; 200tl by QualityMetric IncotpOrated and Medical Outcomes 'l'rust. All Rights Reserved.
SF-36® is i! regi;l~ed ltitdenwk ufMedical OmOOines Tfu.l ' . .
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03

4. Duting the past 4 weeks, how much of the time have you had--any of the
following problems with Y01Ir work or other regular daily activities as a
result of your physical health?

All of Most of Some of A little None of
the time the time the time of the the time
time

• Cut down on the amount of time you spent
on work or other activities ........... .. ............ .............. 01. ........ 0
b

c

d

Accomplished less than you would like ................. . 0

=... ... .. ... .. . . ....

Were limited in the kind of work or other
activities ................

2........ 03 ......... 0 4.........Os

1. ........ 02 ........ 03 ......... 04 ......... Os

0, ......... 02 ........ 03 ......... 04 .........05

Had difficulty performing the work or other
activities (for example, it took extra effort) .... ...... 0, ......... 02 ........ 03.,.......

04 ......... Os

5. During the past 4 weeks, how much of the time have you had any of the
following problems with your work or other regular daily activities as a
result of any emotional problems (such as feeling depressed or anxious)?
Al1 of Most of Some of A little None of
the time the time the time of the the time
time

• Cut down on the amount oftime you spent
on work or other activities .......... ..... .. .................... 0, ......... 02 ........ 03 ......... 0
b

c

Accomplished less than you would like ..... .... ....... 0, .........02 ........ 03 ......... 04 ........ Os
Did work or other activities less carefully
than usual. .... .... .. ...... ... ..... ............... .. ........... ..... .. ... 0, .........0

2........ 03 ......... 04 ........ Os

SF-36v2TMHealth Swv!')'@ 1996,2000 by QualityMetric Incorporated and Medical Outcomes Trust. All Rights Reserved.
SF-36® is a registered tmdemark o~ Medical Outcot,nos Trust
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6. During the past 4. weeks., to what extent has your pbysical heaUh or
emotional problems interfered with your normal social activities with
family, friends, neighbors, or groups?
Not at all

Slightly

Moderately

u.

Quite a bit

Extremely

O.

7. How much bodily pain have you had during the past 4 weeks?
l'1one

Very mild

:Mild

Moderate

Severe

Very Severe

O.

8. Durblg the past 4 weeks, how much did. pain interfere with your normal
work (including both work outside the home and housework)?
Not at all

A li.ttlebit

Moderately

Quite a bit

Extremely

O.

OJ

SF-36v2 TWHcalth Survey ©. 1996, 2000 by QualityMetric Incorpornted and Medical Outcomes Trust AIl Rights ReseI:Ved.
$F-36® is aregis[ered ~~ark of Medical Outcoines Trust
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9. These questions are about how you feel and how tbi~s have been with you
during the past 4 weeks. For each question, please give the one answer
tbat comes dosest to the way youbave been feeling~ How much of the time
duIing the past 4 weeks ...

j

I
I

~
b'

All of Most of Some of A little
the time the time the time of the
time

ofl

J
None
the time

Did you feel full ofiife? ........ ... .. ............ ............. 01. ......... 02 .........03 .......... 04 ......... Os
Have you been very nervous? .......... ...... ..... ...... .. 01 ...... .. .. 0 2..........03 .......... 04 ......... Os

Have you felt so dovm in the dumps
. that nothing could cheer you up? .. ................ ......

<

01. ......... Oi ........ -03 .......... 04 ......... Os

d

Have you felt calm and peaceful? .................. .. ...

01 .......... 0 2.......... 03 .......... 04 ......... Os

c

Did you have a lot of energy? ...... .... ............ .......

01. ......... 02 .......... 03 .......... 04 ......... Os

Have you felt downhearted and
depressed? .... .. .. ..... .... ..... .......... ......... .... ....... ... .. ..

01 .......... 02 .......... 03 .......... 04 ......... Os

g

Did you feel worn out? .. .. ...... ........... .. .... .. ...... .....

01. ......... 02 .......... 03 .......... 04 ......... Os

h

Have you been happy? ..... ......... .. .. .... ..................

01. ......... 02 ..........03 .......... 04 ......... Os

i

Did you feel tired? .... ...... .. .. .......... ..... .. .... .. .. ..... ...

01 .......... 02 .......... 03 .......... 04 ......... Os

f

10. During the past 4 weeks, how much of the time has your physical health
or emotional problems interfered with your social activities (like visiting
friends, relatives, etc.)?
All of the
time

Most of the
time

Some of the
time

A little of the
time

None of the
time

SF-36v2TMHealth Survey © 1996, 2000 by QualityMetric Incorporated and Medical Outcomes Trust. All rughts ReseTVed.
SF-36® is a registered trademark of Medical Outcomes Trust.
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j

11. How TRUE or FALSE is each of the following statements for you?
Definitely
true

Mostly
true

Don't
know

Mostly
false

Definitely
false

• I seem to get siCk a little easier
than other people .................................... 01 ............ 02 ........... 03 ,.......... 04 ........... Os

........... 04 ........... Os

b

I am as healthy as anybody I know ........ 01 ............ 02 ........... Q

<

I expect my health to get worse .............. 01 ............ 02 ........... 03 ........... 04 ..... ....-..05

d

My health is excellent.. .......................... 0, ............ 02 ........... O~ ........... 04 ........... D,

THANK YOU FOR COMPLETING THESE OUEST/ONSI

SF-36v2™ Health Survey © 1996;2000by QualityMctric Incorporated and Medical Outcomes Trust. All Rights Reserved.

SF-36® is a registered trademark of Medica) Op!cornos Trust.
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APPENDIX C

Have you been diagnosed with Osteoarthritis of
the knee or hip?

I

·,"

.'

((~\
Do you have pain associated with your
Osteoarthritis?
Are you not currently seeking treatment for your
pain?
Would you like to assist in furthering research on
Magnetic Insoles and ·their effect on pain and
functional abilities?
If you answer yes to the above questions you may be
eligible to participate in our study and receive free
foot ~creenings.
:

J~

'.' ~~ ..
~

For more information contact Janice and Jenny at
772-7600
7
7

7
7

7
7

7
7

7
7

7
7

7
7

7
7

7
7

7
7

7
7

2

2

2

2

2

2

2

2

2

2

2

7

7

7

7

7

7

7

7

7

7

7

6
0
0

6
0
0

6
0
0

6
0
0

6
0
0

6
0
0

6
0
0

6
0
0

6
0
0

6
0
0

6
0
0
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APPENDIXD

University of North Dakota Human Subjects Review Form
All research with human participants conducted by faculty, staff, and students associated with the University of North Dakota,
must be reviewed and approved as prescribed by the University's policies and procedures governing the use of human subjects.
It is the intent of the University of North Dakota (UND), through the Institutional Review Board (IRE) and Research
Development and Compliance (RD&C), to assist investigators engaged in human subject research to conduct their research
along ethical guidelines reflecting professional as well as community standards. The University has an obligation to ensure
that all research involving human subjects meets regulations established by the United States Code of Federal Regulations
(CFR). When completing the Human Subjects Review Form, use the "IRE Checklist" for additional guidance.
Please provide the information requested below:
Principal Investigator: Dr. Sue Jeno, PT, Janice Holth, Jenny Surma, Sarah Barendt
Telephone:

E-mail Address:

701-777-2831

sujeno@m~icine.nodak.edu

-----------------------Complete Mailing Address: P.O. Box 9037, UND Dept. of Physical Therapy, Grand Forks, ND 58202
SchooVCollege: University of North Dakota
Student Adviser (if applicable):
Telephone:

701-777-2831

Department:

Physical Therapy

--~------~-----------------

Dr. Sue Jeno
------------------------------------------------------E-mail Address: sujeno@medicine.nodak.edu

Address or Box #: P.O. Box 9037, UND Department of Physical Terapy
Department: Physical Therapy

SchooVCollege: University of North Dakota

Project Title: The Short-term Effects of Magnetic Insoles on Pain and Function in a Population with
Lower Extremity Osteoarthritis: A Pilot Study
Proposed Project Dates: Beginning Date:

May 23, 2005

----~--~---------

Completion Date:

May 23, 2006
(Including data analysis)

--~~~~--~~-

Funding agencies supporting this research: University of North Dakota, Department of Physical Therapy

(A copy o/the/unding proposal/or each agency identified above MUST be attached to this proposal when submitted.)

YES or X NO

Does the Principal Investigator or any researcher associated with this project have a financial interest
in the results of this project? If yes, please submit, on a separate piece of paper, an additional
explanation of the financial interest (other than receipt of a grant)

If your project has been or will be submitted to other IRBs, list those Boards below, along with the status of each proposal.
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Date submitted: _ _ _ _ _ Status: ___ Approved ___ Pending
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Date submitted: _ _ _ _ _ Status: ___ Approved __ Pending
Type of Project: Check "Yes" or "No" for each of the following.
X

X

YES or

NO

New Project

YES or X

NO

ContinuationlRenewal

YES or X

NO

YES or X

NO

YES or X

NO

YES or X

NO

YES or X

NO

Is this a Protocol Change for previously approved project? If yes, submit a signed copy of this form
with the changes bolded or highlighted.
Does your project involve medical record information? If yes, complete the HIPAA Compliance
Application and submit it with this form.
Does your project include Genetic Research? If yes, refer to Chapter 3 of the Researcher Handbook
for additional guidelines regarding your topic.
Does your project include Internet Research? If yes, refer to Chapter 3 of the Researcher Handbook
for additional guidelines regarding your topic.
Will subjects or data be provided by Altru Health Systems? If yes, submit two copies of the
proposal. A copy of the proposal will be provided to Altru.

YES or

NO

Will research subjects be recruited at another organization (e.g., hospitals, schools, YMCA) or will
assistance with the data collection be obtained from another organization?

X
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YES or X

NO

Dissertationrrhesis

YES or

NO

Student Research Project

If yes, list all institutions: Valley 400, Center Court Fitness, Select Therapy and Fitness, Grand Forks Senior Citizens' Center
Letters fro"m each organization must accompany this proposal. Each letter must illustrate that the organization understands
their involvement in that study, and agrees to participate in the study. Letters must include the name and title of the
individual signing the letter and, if possible, should be printed on letterhead.
Subject Classification: This study will involve subjects who are in the following special populations: Check all that apply.
Minors « 18 years)

UND Students

Prisoners

Pregnant W omenlFetuses

Persons with impaired ability to understand their involvement and/or consequences of participation in this research
_X
__ Other Adults >18 years with diagnosed osteoarthritis of the hip and/or knee
For information about protections for each of the special populations, refer to Chapter 5 of the Researcher Handbook.
This study will involve: Check all that apply.
_ _ _ Deception

Stem Cells
Discarded Tissue

Radiation
New Drugs (IND)

Fetal Tissue

_ _ _ Non-approved Use of Drug(s)

Human Blood or Fluids
Other

Recombinant DNA
X

None of the above will be involved in this study

I. Project Overview
Please provide a brief explanation (limit to 200 words or less) of the rationale and purpose of the study, introduction of any
sponsor(s) of the study, and justification for use of human subjects and/or special populations (e.g., vulnerable populations such
as minors, prisoners, pregnant women/fetuses).
Magnetic therapy has been used for centuries for healing and reduction of pain from the ancient Greek usage of Loadstones to
Mesmer's usage of magnetic iron rods. The effects of magnets on the human body include: reduction of fluid retention and
inflammation, decreased pain, and increased circulation. In today's markets it is possible to buy magnetic de:.vices ranging from
jewelry to mattress pads and from insoles to horse blankets. Magnetic insoles are marketed as being used for reducing pain in feet,
legs, joints, and low back. Osteoarthritis pain is also closely correlated with decreased function. The purpose of this study is to
evaluate the short-term effects of magnetic insoles on lower extremity osteoarthritis and function. The study will include 14
participants with osteoarthritis, 2 randomly assigned groups of 7, who will wear over-the-counter magnetic insoles or generic nonmagnetic insoles for 2 weeks. For one week no insoles will be worn, and then the groups will switch and wear the other type of
insole for 2 weeks. Function, pain, and foot status will be assessed prior to, during, and after treatment. Our goal is to evaluate the
beneficial use of magnets to apply them to this patient population in a therapeutic setting.
II. Protocol Description
Please provide a succinct description of the procedures to be used by addressing the instructions under each of the following
categories. Individuals conducting clinical research please refer to the "Guidelines for Clinical-Research Protocols" on the
Research and Program Development website.
1. Subject Selection.

a) Describe recruitment procedures (i.e., how subjects will be re9ruited, who will recruit them, where and when they will be
recruited and for how long) and include copies of any advertisements, fliers, etc., that will be used to recruit subjects. If
incentive payments will be made to anyone for enrolling participants, describe the incentive package.
Participants who have diagnosed lower extremity osteoarthritis will be voluntarily recruited from various local
organizations including: Valley 400, Center Court Fitness, Select Therapy and Fitness, Grand Forks Senior Citizens'
Center using fliers (see attached) put up at these establishments.
b) Describe your subject selection procedures and criteria, paying special attention to the rationale for including subjects from
any of the categories listed in the "Subject Classification" section above.
Flyers will be posted in various chUrches, organizations, and fitness centers around the area to find subjects willing to
participate in this research. Once potential subjects contact the investigators, a consent questionnaire will be administered
to ensure participants are at minimal risk and qualified to meet the standards required to be included in the research.
Subjects selected from the population will have physician diagnosed osteoarthritis of the hip(s) and/or knee(s) to fulfill our
research goal to find out if magnetic insoles have any effect on pain and function in people with this condition and to "
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further conclude if magnetic therapy may be used as an aspect of treatment to improve the lives of people with
osteoarthritis.
c) Describe your exclusionary criteria and provide a rationale for excluding subject categories.
Exclusion criteria include: persons who are pregnant, have a pacemaker, cochlear implant, implanted insulin pump, or
TENS unit, have open sores or are on anticoagulant medications, have a history of platelet disorder, myasthenia gravis,
hyperthyroidism, autoimmune inflammatory disease, spinal neoplasm, cancer, and those individuals who fail an initial foot
examination. Pregnant women are excluded because at this time the effects of magnets on fetuses are unknown. Those
persons with implanted devices are excluded due to the fact that the magnetic fields may disrupt these devices. Due to the
increased circulation that can be cased by magnets and the possibility of increased bleeding, those persons with open,
bleeding sores, are on anticoagulants, or have a history of platelet disorder or cancer are excluded. People who fail the foot
exam, or any subsequent foot exams throughout the study, will be excluded due to increased risk of co-morbidities and
possible risks to further harm their foot health by using new orthotics for shoe wear.
d) Describe the estimated number of subjects that will participate and the rationale for using that number of sUbjects.
Approximately 14 participants are needed, with 7 participants randomly assigned in each of two groups. Fourteen
participants was the amount chosen because this is a pilot study and statistical analysis needs to be performed on the data
collected from these subjects. The number of subjects will be used to add power and validity to the statistical analysis of
this study.
e) Specify the potential for valid results. If you have used a power analysis to determine the number of subjects, describe
your method.
The results found with this study may either indicate further research or show no effects on pain and function in people with
lower extremity osteoarthritis.

2. Description of Methodology.
a) Describe the procedures used to obtain informed consent.
Prior to testing, participants will be asked to read and sign the attached consent form, and they will be provided with a
copy of this form for their records.
b) Describe where the research will be conducted. Document the resources and facilities to be used to carry out the proposed
research. Please note staffing, funding, and space available to conduct this research.
This study will take place in a private room at the University of North Dakota School of Medicine and Health Sciences in
the Physical Therapy department, staffed by the investigators. The funding for this study is from the UND Department of
Physical Therapy and the investigators.
c) Indicate who will carry out the research procedures.
Procedures will be carried out by Janice Holth, Jennifer Surma, and Sarah Barendt under the supervision of Dr. Sue Jeno,
PT.
d) Briefly describe the procedures and techniques to be used and the amount of time that is required by the subjects to
complete them.
Participants are asked to wear the shoes which they will wear for at least 8 hours each day during the study. During the
first day of evaluation they will be asked to complete a pain assessment on the Visual Analog Scale (VAS), SF-36v2
functional questionnaire, receive an initial foot examination, and sign the consent form. The participants will be given a
copy of the consent form at that time. The investigators will then make a photocopy or tracing of their insoles from their
shoes as to accurately size the insoles to be worn for the study. The investigators will fit their shoes with the insoles
which have been randomly assigned to them. Once fit has been established, each will be given a wearing and activity log
which they will be asked to record the hours they wear their shoes with the insoles each day and general activities
performed while wearing the shoes with insoles. We ask that they try to wear them at least 8 hours per day during this
study. This part of the study will take approximately 30-45 minutes.
After one week we will call each particip'ant to ask for a pain assessment on the V AS and check the fit of the insoles.
This will take approximately 5 miputes.
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At the end of two weeks, we will reassess their pain on the VAS, and overall function by completing the SF-36v2. We
will ask that they bring their wearing and activity log. The participation in this step should last approximately 20-30
minutes.
For a period of at least 1 week following the frrst trial, no insoles with be worn by the participants. At the end of this
week, they will return to be refit with new insoles. They will give a pain assessment on the VAS, fill out the SF-36v2,
and receive a new wearing and activity log. This step's participation should take approximately 30 minutes.
Following a week of wearing the second pair of insoles, we will call each participant to ask for a pain assessment on the
VAS and check the fit of the insoles. Participation in this call should take approximately 5 minutes.
At the end of these 2 weeks, we will again reassess their pain on the VAS, and they will fill out the SF36v2. We will ask
that they bring their wearing and activity log. Their feet will receive a final assessment at this time to ensure they have
maintained the health of their feet. This portion of the study will take approximately 30 minutes.
e) Describe audio/visual procedures and proper disposal of tapes.
f) Describe the qualifications of the individuals conducting all procedures used in the study.

Dr. Sue Jeno is on faculty in the PT Department and has training in the procedures utilized in this study. Janice Holth,
Jenny Surma, and Sarah Barendt are second year students in the Doctor of Physical Therapy program at the University of
North Dakota. They have taken coursework and are taking courses that give them the competency to perform the research
proposed to fulfill their educational research project required to graduate from this program. They have been trained in the
proper techniques of foot assessment and administration of the SF-36 and Visual Analog Scale for pain.
g) Describe compensation procedures (payment or class credit for the subjects, etc.).
The compensation for participation in this study will be the 2 pairs of insoles worn during the study and foot screenings.
Attachments Necessary: Copies of all instruments (such as survey/interview questions, data collection forms completed by
subjects, etc.) must be attached to this proposal.

3. Risk Identification.
a) Clearly describe the anticipated risks to the subject/others including any physical, emotional, and financial risks that might
result from this study.
The risks associated with this study are minimal, but these risks will be monitored and controlled. Limited physical risks
could include foot pain, blisters, or tingling. Emotional risks may include the subjects becoming slightly discouraged if
anticipating an improvement in their condition and these benefits are not achieved. Proper subject screening and foot
assessments will be completed prior to the study to minimize these possible risks.
b) Indicate whether there will be a way to link subjec~ responses and/or data sheets to consent forms, and if so, what the
justification is for having that link.
To maintain confidentiality, participants are identified by a numerical code only with data stored in separate, locked
cabinets within the Department of Physical Therapy. Information will only be presented in aggregate form and identifiable
only to the investigators and advisor of this study for data analysis purposes.

4. Subject Protection.
a) Describe precautions you will take to minimize potential risks to the subjects (e.g., sterile conditions, informing subjects
that some individuals may have strong emotional reactions to the procedures, debriefing, etc.).
Subjects will be informed of the procedures, purpose, and time involved in this study prior to participation. Subjects will
sign a consent form and be provided a copy for their records. Subjects will be informed that they may withdraw from the
study at any time without any repercussions. Foot assessments will be performed prior to and throughout the study to
maintain foot quality and ensure participants who enter the study have healthy feet. Fit of insoles will also be reassessed
throughout the study to prevent potential risks associated with wearing the insoles.
b) Describe procedures you will implement to protect confidentiality (such as coding subject data, removing identifying
information, reporting data in aggregate form, etc.).
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To maintain confidentiality, participants are identified by a numerical code only and data will be stored separate from
consent forms in locked file cabinets within the Department of Physical Therapy. Information will only be presented in
aggregate form and identifiable only to the investigators and advisor of this study.
c) Indicate that the subject will be provided with a copy of the consent form and how this will be done.
Each subject will be provided a copy of the consent form personally from the investigators at the first visit, prior to
beginning the study.
d) Describe the protocol regarding record retention. Please indicate that research data from this study and consent forms
will both be retained in separate locked locations for a minimum of three years following the completion of the study.
Describe: 1) the storage location of the research data (separate from consent forms and subject personal data)
2) who will have access to the data
3) how the data will be destroyed
4) the storage location of consent forms and personal data (separate from research data)
5) how the consent forms will be destroyed
Data will be stored separate from consent forms in locked file cabinets within the Department of Physical Therapy. The
only people who will have access to this information being the investigators, advisor, and IRE auditing staff. Data will
be kept for three years after the completion of the study, at which time the information will be shredded.
e) Describe procedures to deal with adverse reactions (referrals to helping agencies, procedures for dealing with trauma, etc.).
In the event that this research activity results in a physical injury, medical treatment will be readily available, including
first aid, emergency treatment and follow-up care as it is to any member of the general public in similar circumstances.
Payment for any treatment must be provided by the subject or the subject's third party payer, if applicable.
f) Include an explanation of medical treatment available if injury or adverse reaction occurs and responsibility for costs
involved.
In the unlikely event that this research activity results in injury, medical treatment will be available, including first aid,
emergency treatment and follow-up care as it is to the general public in similar circumstances. The pt:rson and their third
party payer must provide payment for any such treatment.

III. Benefits of the Study
Clearly describe the benefits to the subject and to society resulting from this study (such as learning experiences, services
received, etc.). Please note: payment is not a benefit and should be listed in the Protocol Description section under
Methodology.
Advancement of research in the area of the use of magnetic insoles in the therapeutic setting is the ultimate goal of this study.
The participants will learn about magnetic therapy and potentially experience its positive effects on their osteoarthritis pain and
function. The knowledge gained in this study may aid all involved in their future decisions regarding the use of magnetic
therapy.
IV. Consent Form
A copy of the consent form must be attached to this proposal. If no consent form is to be used, document the procedures to be
used to protect human subjects. Refer to the RD&C website for further information regarding consent form regulations.
Please note: Regulations require that all consent forms, and all pages of the consent forms, be kept for a minimum of 3
years after the completion of the study, even if the subject does not continue participation.
By signing below, you are verifying that the information provided in the Human Subjects Review Form and attached
information is accurate and that the project will be completed as indicated.
Signatures:
(principal Investigator)

Date:

(Student Adviser)

Date:
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REPORT OF ACTION: EXEMPT/EXPEDITED REVIEW
University of North Dakota Institutional Review Board
Date:

Project Number: IRB-200505-363

5/6/2005

Principal Investigator:
Department:

Jeno, Sue; Holth, Janice; Surma, Jenny; Barendt, Sarah

Physical Therapy

Project Title: The Short-Term Effects of Magnetic Insoles on Pain and Function in a Population with Lower Extremity
Osteoarthritis: A Pilot Study
The above referenced project was reviewed by a designated member for the University's Institutional Review Board
on '
May 9, 2005
and the following action was taken:

-d Project approved . Expedited Review Category No. _ _ _ _ _tft---·_________________
'1J Next scheduled review must be before: _.!-'M""aJ-y--",8..., -""2"'-0"'-0"'-6_____________________

¢

Copies of the attached consent form with the IRS approval stamp dated ...,M....ea"-vJ-..,9<...,'--'2=-'0""O,.,,5<--______
. must be used in obtaining consent for this study.

Project approved . Exempt Review Category No. _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
as long as approved procedures are followed. No
periodic review scheduled unless so stated in the Remarks Section.

o This approval is valid until

o Copies of the attached consent form with the IRS approval stamp dated
must be used in obtaining consent for this study.

o Minor modifications required . The required corrections/additions must be submitted to ROC for review and
approval. This study may NOT be started UNTIL final IRS approval has been received.
(See Remarks Section for further information.)
i

o Project approval deferred.

This study may not be started until final IRS approval has been received.
(See Remarks Section for further information.)

REMARKS: Any unanticipated problem or adverse occurrence in the course of the research project must be
reported within 72 hours to the IRS Chairperson or ROC by submitting an Unanticipated
Problem/Adverse Event Form.
Any changes in protocol or Consent Forms must receive IRS approval prior to being
implemented. You must submit a Protocol Change Form with all revised research documents
to include changes to protocol, consent forms, or supportive materials, with the appropriate
signatures, to Research Development and Compliance for review and approval.
PLEASE NOTE: Requested revisions for student proposals MUST include adviser's signature. All revisions
MUST be highlighted.

~ducation Requirements Completed.

(Project cannot be started until IRS education requirements are met.)

cc: Chair, Physical Therapy; Dean, School of
Medicine

If the proposed project (clinical medical) is to be part of a research activity funded by a Federal Agency, a special assurance
statement or a completed 310 Form may be required . Contact RDC to obtain the required documents.

(Revised 07/2004)
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APPENDIXE

Magnetic Insoles
Foot Assessment
ID# _ _ __

1. Are the nails thick, too long, ingrown, or infected with fungal disease? Y

N

2. Note foot deformities

L

R

Toe deformities
Bunions
Charcot foot
Foot drop
Prominent Metatarsal Heads
Amputation

_ _ Specify date, side and level _ _ _ _ _ __

3. Pedal Pulses: (fill in the blanks with a "P or "A" to indicate present or absent).

L

R

Post. Tibial
Dorsalis Pedis
4. Skin Condition: (Measure, draw in and label on foot diagram)
C = Callus
S =Swelling
PU =Pre-ulcerative lesion
U =Ulcer
R = Redness
D =Dryness
W=Warmth
5. Protective Sensation: label with + if participant can feel 4.5 g. monofilament or - if
participant can not feel filament in circled areas.

Recommend Referral?

Y

N
54

APPENDIXF

Magnetic Insoles
Participation Survey
ID#:- - - - - - -

Birthday: _ _ _ __
Gender: M
F
Height _ _ __
Weight _ __
Shoe Size: _ _ __

Do you have osteoarthritis pain in your hip(s) or knee(s)?

Yes

No

In whichjoint(s) is your osteoarthritis pain? _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
Are you currently seeking medical treatment for your osteoarthritis pain?: Yes

No

How would you describe your pain today? _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
How long have you been experiencing this pain? _ _ _ _ _ _ _ _ _ _ _ __
What Medications are you currently taking? _ _ _ _ _ _ _ _ _ _ _ _ _ __
Have you ever worn magnetic insoles?

Yes

No
Yes

Do you believe in magnetic therapy for relieving pain?
Have you had a joint arthroplasty/replacement?

Yes

No

No

If yes, which joint(s)? _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __

Please Circle any that apply to you:
Pregnant

Pacemaker

Cochlear Implant

TENS unit

Insulin Pump

Platelet Disorder

Spinal Neoplasm

Myasthenia Gravis

Hyperthyroidism

other implanted device
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Cancer

APPENDIXG

ID#: - - - The Short-term Effects of Magnetic Insoles on Pain and Function in a population with
Lower Extremity Osteoru1hritis: A Pilot Study

Participant Information and Consent Form
You are invited to participate in a student research study conducted by Janice Holth,
Jennifer Surma, and Sarah Alberts Barendt and faculty advisor, Dr. Sue Jeno, PT of the
University of North Dakota Department of Physical Therapy. The purpose of this study
is to evaluate the effects of magnetic insoles on pain and function of people with
osteoarthritis.
Healthy individuals who do not meet any of the exclusion criteria can be included in this
study. Reasons to be excluded from this study include: persons who are pregnant, have
an implanted devise, have open sores or are on anticoagulant medications, have a history
of platelet disorder, myasthenia gravis, hyperthyroidism, autoimmune inflammatory
disease, spinal neoplasm, cancer. The effects of magnets on the involved structures with
these diagnoses are detrimental to the health of the participant or are unknown at this
time leading to the exclusion of these individuals. Also, if problems are noted during
initial foot assessment, participants will also be excluded.
You will be asked to come to the Dept. of Physical Therapy 4 times during the study.
During the first day of evaluation you will be asked to sign this consent form and
complete the participant survey as well as the pain and function questionnaires. You are
asked to wear or bring the shoes you plan on wearing for the study so the investigators
can assess size and fit your shoes with the insoles randomly assigned to you, magnetic or
non-magnetic. A foot assessment will be completed at this time to assess sensation and
possible complications to wearing the insoles. This part of the study will take
approximately 30-45 minutes of your time.
You will be given a wearing and activity log which you will be asked to record the hours
you wear your shoes with the insoles each day and general activities performed while
wearing the shoes with insoles. We ask that you try to wear these shoes with the insoles
for at least 8 hours per day during this study. After one week, you will receive a phone
call from one of the investigators who will ask about your pain and make sure the insoles
still fit. At the end of two weeks, you will return to UND and we will again reassess your
pain and overall function. We will ask that you bring your wearing and activity log to the
investigators. You will again complete the pain and function questionnaires and a foot
assessment will be done to make sure no changes or sores have occurred. The
participation in this step should last approximately 20-30 minutes.
You will then spend at least one week without any insoles. After which, you will return
to be refit with new insoles, either magnetic or non-magnetic. You will have your feet
reassessed and receive a new wearing and activity log. This step's participation should
take approximately 30 minutes. After one week, you will again receive a phone call from
one of the investigators to assess your pain and the fit of the insoles. At the end of two
weeks, we will reassess your pain and overall function and one last time. We will ask
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that you bring with you to UND, your wearing and activity log and you will again
complete the pain and function questionnaires. Your feet will be reassessed at this time
to ensure health of feet has been maintained. This portion of the study will take
approximately 30 minutes. You will be able to keep the insoles you wore as part of this
study.
The benefits to you, the participant, is possibly experiencing the effects of magnetic
insoles, as well as assisting in medical research which will further the knowledge on the
legitimate uses for magnetic insoles with persons experiencing pain from osteoarthritis.
This study will last 6 weeks, and your compensation will be the insoles worn in this
study.
The anticipated risks associated with participation in this study are minimal and may
involve changes in the condition of your feet. We request that you wear socks with your
shoes and contact the investigators immediately if you feel any discomfort. The foot
assessments are designed to minimize the risk of these problems. If any problems are
developing during the study, you will be removed from the study and referred as
necessary. Basic first aid or emergency treatment will be available as needed as it would
be for the general public and any medical attention will not be covered by this institution
and will have to be covered by you or your third party payer. To maintain
confidentiality, all personal data will be assigned a numerical code, and data from this
study will be stored in locked file cabinets within the Department of Physical Therapy for
three years, after which time it will be shredded. Only the researchers, the advisor, and
people who audit IRB procedures will have access to the data.
Your participation in this study is completely voluntary. Your decision whether or not to
participate in this study will in no way change any future relations with UND. If you do
choose to participate in this study, you or the researches can choose to terminate
participation at any time without penalty. There are no anticipated costs for participation
in this study and you will receive a copy of this consent form for you records.
If you have any question or concerns about this study at any time, please do not hesitate
to contact Dr. Sue Jeno at 777-2831, Janice Holth and Jennifer Surma at 772-7600, Sarah
Alberts Barendt at 885-5110, or Research Development and Compliance at 777-4279.
ALL OF MY QUESTIONS HA VB BEEN ANSWERED AND I AM ENCOURAGED
TO ASK ANY QUESTIONS THAT I MAY HA VB CONCERNING THIS STUDY IN
THE FUTURE. MY SIGNATURE INDICATES THAT, HAVING READ THE
ABOVE INFORMATION; I HAVB DECIDED TO PARTICIPATE IN THE
RESEARCH PROJECT.

Date

Participant

Phone Number and best time to reach you
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APPENDIXH

Magnetic Insoles

Participant Wearing Log
ID#:

Day

Date

Hours Worn

1
2
3

4
5

6
7
8

9
10
11

12
13

14
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